Upstream Medical Technologies Ltd, has just closed a bridging round fully subscribed and over subscribed.
Upstream Medical Technologies closes bridging capital raise round
With the successful close of the bridging round, Upstream is poised to focus on a Series A capital raise aimed at securing funds for an international multicentre clinical trial for its lead unstable angina test, UA Score. This will provide the regulatory approvals and further clinical validation for commercialising UA Score.
See attached press release here
Detecting at-risk heart attack patients, a step closer with $2m investment
Upstream Medical Technologies, a leading deep-tech company focused on developing innovative solutions for heart disease, announced today that it has closed a significant capital round to further advance its frontline diagnostic tests for cardiac diseases.
Upstream commences testing Marker C on the APACE cohort
The next phase of development is now underway, with the commencement of testing Marker C on the APACE cohort.